To read more on this topic click here.
Can a digital pen “revolutionise” Parkinson’s diagnosis?
Author: Sophie BatesPublished: 23 January 2020
Prep: Cook: Serves:
A Parkinson’s diagnosing pen has sealed a five-year manufacturing deal from stationery brand Stabilo.
The Neuromotor Pen– developed by Scottish medical devices company Manus Neurodynamica – analyses a user’s hand and limb movements as they perform a number of drawing tests on a tablet.
Microchips within the device record the data of even the smallest of movements, and determine whether a user has Parkinson’s in a simple and non-invasive way.
Researchers believe the pen could be adapted in the future for use in monitoring patients with Alzheimer’s, multiple sclerosis and those that have suffered from a stroke.
Peter Kämpf, director of research and development at Schwan-Stabilo, said: “This novel product can potentially revolutionise the diagnosis and treatment of neuromotor diseases, and we are excited to be involved in its development and in helping bring it to market.”
For more information on Parkinson’s and assessment tools please visit the EPDA website.
Share this story
New brain chemical pump is “huge step forward” for advanced Parkinson’s
Approval of new dopamine pump welcomed by campaignersREAD MORE
“Brain Surgery Live is a modern medical miracle the public deserved to see”
Exposure for such modern miracles is crucial, argues Justin RossiREAD MORE
“Incompetence, racism and prejudice delayed my diagnosis”
Manon Day on being a young black woman with Parkinson’sREAD MORE